Quick Answer
LifeMD, Inc. reported Cash and Equivalents of $35.00 million for fiscal year 2024.
LifeMD, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $35.00M | +5.6% |
| 2023 | $33.15M | +737.3% |
| 2022 | $3.96M | -90.4% |
| 2021 | $41.33M | +350.2% |
| 2020 | $9.18M | +729.5% |
| 2019 | $1.11M | +514.5% |
| 2018 | $180.1K | +27.4% |
| 2017 | $141.4K | -22.6% |
| 2016 | $182.6K | -21.6% |
| 2015 | $233.0K | +215.4% |
| 2015 | $73.9K | -2.2% |
| 2014 | $75.5K | -51.3% |
| 2013 | $155.1K | +56.7% |
| 2012 | $98.9K | -39.4% |
| 2012 | $163.2K | +387.1% |
| 2011 | $33.5K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $36.23M | +1.5% | +5.3% |
| March 31, 2025 | $34.39M | -2.0% | -1.7% |
| December 31, 2024 | $35.00M | +5.6% | -6.9% |
| September 30, 2024 | $37.59M | +145.9% | +5.3% |
| June 30, 2024 | $35.70M | +199.9% | +1.7% |
| March 31, 2024 | $35.11M | +204.7% | +5.9% |
| December 31, 2023 | $33.15M | +737.3% | +116.8% |
| September 30, 2023 | $15.29M | +161.9% | +28.4% |
- LifeMD, Inc. showed an increase of +5.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2011–2024 period, LifeMD, Inc.’s cash and equivalents has grown by 104386.1% (from $33.5 thousand to $35.00 million).
- The most recent figure is from LifeMD, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 11, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: